FreeTender
Accepting bidstenderRussia

1. ЭЛРАНАТАМАБ (ОКПД2 21.20 – Препараты лекарственные и материалы, применяемые в медицинских целях), 2,2 мл

1. ELRANATAMAB (OKPD2 21.20 – Drugs and materials used for medical purposes), 2.2 mlEnglish, machine translated

Issued by ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ НАУЧНОЕ УЧРЕЖДЕНИЕ "НАУЧНО-ИССЛЕДОВАТЕЛЬСКИЙ ИНСТИТУТ ФУНДАМЕНТАЛЬНОЙ И КЛИНИЧЕСКОЙ ИММУНОЛОГИИ" · via Russia — РТС-тендер procurement (via B2B-Center/OTC aggregator)

Verify & apply on the official portal →
Published
30 Oct 2026
Closes
9 Nov 2026
Value
RUB 2,944,037.67
Reference
0351100021926000612
Location
Новосибирская область, Russia
Sector
Healthcare & Pharma
Type
goods

At a glance

ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ НАУЧНОЕ УЧРЕЖДЕНИЕ "НАУЧНО-ИССЛЕДОВАТЕЛЬСКИЙ ИНСТИТУТ ФУНДАМЕНТАЛЬНОЙ И КЛИНИЧЕСКОЙ ИММУНОЛОГИИ" in Russia has published a tender in healthcare & pharma: “1. ЭЛРАНАТАМАБ (ОКПД2 21.20 – Препараты лекарственные и материалы, применяемые в медицинских целях), 2,2 мл”. Submissions close on 9 November 2026, 10 days from today. The stated value is RUB 2,944,037.67. Quote reference 0351100021926000612 in any correspondence with the buyer. FreeTender has recorded 24 notices from this buyer since 2026, 8 of them currently open. There are 22,702 open healthcare & pharma notices in Russia on FreeTender. Bids are submitted to the buyer through Russia — РТС-тендер procurement (via B2B-Center/OTC aggregator), not through FreeTender.

English summary

Machine translated from Russian by FreeTender. The original notice below is the binding text.

Elranatamab Purchase object: 1. ELRANATAMAB (OKPD2 21.20 – Drugs and materials used for medical purposes), 2.2 ml 2. ELRANATAMAB (OKPD2 21.20 – Drugs and materials used for medical purposes), 9.5 ml Law: 44-FZ. Procurement method: Electronic auction. Site: RTS Tender. Initial (maximum) price: 2,944,037.67 . Organizer: Federal State Budgetary Scientific Institution "Scientific and Research Institute of Fundamental and Clinical Immunology". Region: Novosibirsk region. Reception of applications until: 09.11.2026 03:00 (MSK).

Details

Элранатамаб

Объект закупки:

1. ЭЛРАНАТАМАБ (ОКПД2 21.20 – Препараты лекарственные и материалы, применяемые в медицинских целях), 2,2 мл 2. ЭЛРАНАТАМАБ (ОКПД2 21.20 – Препараты лекарственные и материалы, применяемые в медицинских целях), 9,5 мл Закон: 44-ФЗ. Способ закупки: Электронный аукцион. Площадка: РТС-ТЕНДЕР. Начальная (максимальная) цена: 2 944 037.67 ₽. Организатор: ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ НАУЧНОЕ УЧРЕЖДЕНИЕ "НАУЧНО-ИССЛЕДОВАТЕЛЬСКИЙ ИНСТИТУТ ФУНДАМЕНТАЛЬНОЙ И КЛИНИЧЕСКОЙ ИММУНОЛОГИИ". Регион: Новосибирская область. Приём заявок до: 09.11.2026 03:00 (МСК).

Извещение в ЕИС: https://zakupki.gov.ru/epz/order/notice/ea20/view/common-info.html?regNumber=0351100021926000612

Страница процедуры на площадке: http://www.rts-tender.ru/auctionsearch/ctl/procDetail/mid/691/number/0351100021926000612/etpName/fks

Context for bidders

We hold 24 notices from ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ НАУЧНОЕ УЧРЕЖДЕНИЕ "НАУЧНО-ИССЛЕДОВАТЕЛЬСКИЙ ИНСТИТУТ ФУНДАМЕНТАЛЬНОЙ И КЛИНИЧЕСКОЙ ИММУНОЛОГИИ", going back to October 2026 — 8 of them still open. They buy mostly in Healthcare & Pharma, Manufacturing & Supply and Chemicals & Materials. There are 22,702 open Healthcare & Pharma tenders in Russia. This one closes in 10 days.

Similar Healthcare & Pharma tenders

Before you bid on this tender

A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.

  • Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
  • Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
  • Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
  • Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
  • Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
  • Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
Common bidding mistakes to avoid →Writing a winning proposal

More Healthcare & Pharma tenders

All Healthcare & Pharma tenders →

FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.

Verify & apply on the official portal →